Differential activation of Epidermal Growth Factor (EGF) receptor downstream signaling pathways by betacellulin and EGF

Tsugumichi Saito, Shuichi Okada, Kihachi Ohshima, Eijiro Yamada, Minoru Sato, Yutaka Uehara, Hiroyuki Shimizu, Jeffrey E. Pessin, Masatomo Mori

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

To determine the downstream signaling pathways regulated by betacellulin (BTC) in comparison with epidermal growth factor (EGF), we used Chinese hamster ovary cells overexpressing the human EGF receptor (ErbB1/EGFR). The overall time-dependent activation of EGFR autophosphorylation was identical in cells treated with 1 nM BTC or 1.5 nM EGF. Analysis of site-specific EGFR phosphorylation demonstrated that the BTC and EGF tyrosine phosphorylation of Y1086 was not significantly different. In contrast, the autophosphorylation of Y1173 was markedly reduced in BTC-stimulated cells, compared with EGF stimulation that directly correlated with a reduced BTC stimulation of Shc tyrosine phosphorylation, Ras, and Raf-1 activation. On the other hand, Y1068 phosphorylation was significantly increased after BTC stimulation, compared with EGF in parallel with a greater extent of Erk phosphorylation. Expression of a dominant interfering MEK kinase 1 (MEKK1) and Y1068F EGFR more efficiently blocked the enhanced Erk activation by BTC, compared with EGF. Interestingly BTC had a greater inhibitory effect on apoptosis, compared with EGF, and expression of Y1068F EGFR abolished this enhanced inhibitory effect. Together, these data indicated that although BTC and EGF share overlapping signaling properties, the ability of BTC to enhance Erk activation occurs independent of Ras. The increased BTC activation results from a greater estent of Y1068 EGFR tyrosine phosphorylation and subsequent increased recruitment of the Grb2-MEKK1 comples to the plasma membrane, compared with EGF stimulation. The increased Erk activation by BTC associated with antiapoptotic function.

Original languageEnglish (US)
Pages (from-to)4232-4243
Number of pages12
JournalEndocrinology
Volume145
Issue number9
DOIs
StatePublished - Sep 2004
Externally publishedYes

Fingerprint

Epidermal Growth Factor Receptor
Epidermal Growth Factor
Phosphorylation
MAP Kinase Kinase Kinase 1
Tyrosine
Betacellulin
Cricetulus
Ovary
Cell Membrane
Apoptosis

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Saito, T., Okada, S., Ohshima, K., Yamada, E., Sato, M., Uehara, Y., ... Mori, M. (2004). Differential activation of Epidermal Growth Factor (EGF) receptor downstream signaling pathways by betacellulin and EGF. Endocrinology, 145(9), 4232-4243. https://doi.org/10.1210/en.2004-0401

Differential activation of Epidermal Growth Factor (EGF) receptor downstream signaling pathways by betacellulin and EGF. / Saito, Tsugumichi; Okada, Shuichi; Ohshima, Kihachi; Yamada, Eijiro; Sato, Minoru; Uehara, Yutaka; Shimizu, Hiroyuki; Pessin, Jeffrey E.; Mori, Masatomo.

In: Endocrinology, Vol. 145, No. 9, 09.2004, p. 4232-4243.

Research output: Contribution to journalArticle

Saito, T, Okada, S, Ohshima, K, Yamada, E, Sato, M, Uehara, Y, Shimizu, H, Pessin, JE & Mori, M 2004, 'Differential activation of Epidermal Growth Factor (EGF) receptor downstream signaling pathways by betacellulin and EGF', Endocrinology, vol. 145, no. 9, pp. 4232-4243. https://doi.org/10.1210/en.2004-0401
Saito, Tsugumichi ; Okada, Shuichi ; Ohshima, Kihachi ; Yamada, Eijiro ; Sato, Minoru ; Uehara, Yutaka ; Shimizu, Hiroyuki ; Pessin, Jeffrey E. ; Mori, Masatomo. / Differential activation of Epidermal Growth Factor (EGF) receptor downstream signaling pathways by betacellulin and EGF. In: Endocrinology. 2004 ; Vol. 145, No. 9. pp. 4232-4243.
@article{75d94706948945b6ba928821bac6b9d2,
title = "Differential activation of Epidermal Growth Factor (EGF) receptor downstream signaling pathways by betacellulin and EGF",
abstract = "To determine the downstream signaling pathways regulated by betacellulin (BTC) in comparison with epidermal growth factor (EGF), we used Chinese hamster ovary cells overexpressing the human EGF receptor (ErbB1/EGFR). The overall time-dependent activation of EGFR autophosphorylation was identical in cells treated with 1 nM BTC or 1.5 nM EGF. Analysis of site-specific EGFR phosphorylation demonstrated that the BTC and EGF tyrosine phosphorylation of Y1086 was not significantly different. In contrast, the autophosphorylation of Y1173 was markedly reduced in BTC-stimulated cells, compared with EGF stimulation that directly correlated with a reduced BTC stimulation of Shc tyrosine phosphorylation, Ras, and Raf-1 activation. On the other hand, Y1068 phosphorylation was significantly increased after BTC stimulation, compared with EGF in parallel with a greater extent of Erk phosphorylation. Expression of a dominant interfering MEK kinase 1 (MEKK1) and Y1068F EGFR more efficiently blocked the enhanced Erk activation by BTC, compared with EGF. Interestingly BTC had a greater inhibitory effect on apoptosis, compared with EGF, and expression of Y1068F EGFR abolished this enhanced inhibitory effect. Together, these data indicated that although BTC and EGF share overlapping signaling properties, the ability of BTC to enhance Erk activation occurs independent of Ras. The increased BTC activation results from a greater estent of Y1068 EGFR tyrosine phosphorylation and subsequent increased recruitment of the Grb2-MEKK1 comples to the plasma membrane, compared with EGF stimulation. The increased Erk activation by BTC associated with antiapoptotic function.",
author = "Tsugumichi Saito and Shuichi Okada and Kihachi Ohshima and Eijiro Yamada and Minoru Sato and Yutaka Uehara and Hiroyuki Shimizu and Pessin, {Jeffrey E.} and Masatomo Mori",
year = "2004",
month = "9",
doi = "10.1210/en.2004-0401",
language = "English (US)",
volume = "145",
pages = "4232--4243",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Differential activation of Epidermal Growth Factor (EGF) receptor downstream signaling pathways by betacellulin and EGF

AU - Saito, Tsugumichi

AU - Okada, Shuichi

AU - Ohshima, Kihachi

AU - Yamada, Eijiro

AU - Sato, Minoru

AU - Uehara, Yutaka

AU - Shimizu, Hiroyuki

AU - Pessin, Jeffrey E.

AU - Mori, Masatomo

PY - 2004/9

Y1 - 2004/9

N2 - To determine the downstream signaling pathways regulated by betacellulin (BTC) in comparison with epidermal growth factor (EGF), we used Chinese hamster ovary cells overexpressing the human EGF receptor (ErbB1/EGFR). The overall time-dependent activation of EGFR autophosphorylation was identical in cells treated with 1 nM BTC or 1.5 nM EGF. Analysis of site-specific EGFR phosphorylation demonstrated that the BTC and EGF tyrosine phosphorylation of Y1086 was not significantly different. In contrast, the autophosphorylation of Y1173 was markedly reduced in BTC-stimulated cells, compared with EGF stimulation that directly correlated with a reduced BTC stimulation of Shc tyrosine phosphorylation, Ras, and Raf-1 activation. On the other hand, Y1068 phosphorylation was significantly increased after BTC stimulation, compared with EGF in parallel with a greater extent of Erk phosphorylation. Expression of a dominant interfering MEK kinase 1 (MEKK1) and Y1068F EGFR more efficiently blocked the enhanced Erk activation by BTC, compared with EGF. Interestingly BTC had a greater inhibitory effect on apoptosis, compared with EGF, and expression of Y1068F EGFR abolished this enhanced inhibitory effect. Together, these data indicated that although BTC and EGF share overlapping signaling properties, the ability of BTC to enhance Erk activation occurs independent of Ras. The increased BTC activation results from a greater estent of Y1068 EGFR tyrosine phosphorylation and subsequent increased recruitment of the Grb2-MEKK1 comples to the plasma membrane, compared with EGF stimulation. The increased Erk activation by BTC associated with antiapoptotic function.

AB - To determine the downstream signaling pathways regulated by betacellulin (BTC) in comparison with epidermal growth factor (EGF), we used Chinese hamster ovary cells overexpressing the human EGF receptor (ErbB1/EGFR). The overall time-dependent activation of EGFR autophosphorylation was identical in cells treated with 1 nM BTC or 1.5 nM EGF. Analysis of site-specific EGFR phosphorylation demonstrated that the BTC and EGF tyrosine phosphorylation of Y1086 was not significantly different. In contrast, the autophosphorylation of Y1173 was markedly reduced in BTC-stimulated cells, compared with EGF stimulation that directly correlated with a reduced BTC stimulation of Shc tyrosine phosphorylation, Ras, and Raf-1 activation. On the other hand, Y1068 phosphorylation was significantly increased after BTC stimulation, compared with EGF in parallel with a greater extent of Erk phosphorylation. Expression of a dominant interfering MEK kinase 1 (MEKK1) and Y1068F EGFR more efficiently blocked the enhanced Erk activation by BTC, compared with EGF. Interestingly BTC had a greater inhibitory effect on apoptosis, compared with EGF, and expression of Y1068F EGFR abolished this enhanced inhibitory effect. Together, these data indicated that although BTC and EGF share overlapping signaling properties, the ability of BTC to enhance Erk activation occurs independent of Ras. The increased BTC activation results from a greater estent of Y1068 EGFR tyrosine phosphorylation and subsequent increased recruitment of the Grb2-MEKK1 comples to the plasma membrane, compared with EGF stimulation. The increased Erk activation by BTC associated with antiapoptotic function.

UR - http://www.scopus.com/inward/record.url?scp=4344683428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344683428&partnerID=8YFLogxK

U2 - 10.1210/en.2004-0401

DO - 10.1210/en.2004-0401

M3 - Article

C2 - 15192046

AN - SCOPUS:4344683428

VL - 145

SP - 4232

EP - 4243

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 9

ER -